What is EBR Systems?
Founded in 2003, EBR Systems is a specialized medical device manufacturer dedicated to advancing treatments for cardiac rhythm diseases. The company is best known for developing the WiSE Cardiac Resynchronization Therapy system, which offers a physiologic approach to cardiac pacing. By providing a leadless alternative to traditional methods, the company addresses critical gaps in cardiac management for patients and healthcare providers in North America and Oceania.
The firm operates at the intersection of high-stakes medical innovation and clinical application, serving both business-to-business and business-to-consumer segments. Its market position is defined by its ability to translate complex engineering into life-saving clinical outcomes, positioning it as a key player in the evolving landscape of cardiac health technology.
How much funding has EBR Systems raised?
EBR Systems has raised a total of $200.9M across 10 funding rounds:
Unspecified
$15M
Series D
$5M
Private Equity
$18.7M
Private Equity
$20M
Private Equity
$50M
Other Financing Round
$30M
Debt
$1M
Unspecified (2009): $15M featuring Delphi Ventures and Split Rock Partners
Series D (2011): $5M, investors not publicly disclosed
Private Equity (2014): $18.7M with participation from The Foundry, ReShape Lifesciences, Delphi Ventures, and Split Rock Partners
Private Equity (2015): $20M led by SV Life Sciences, Emergent Medical Partners, Delphi Ventures, and Split Rock Partners
Private Equity (2017): $50M supported by Emergent Medical Partners, Ascension Ventures, M.H. Carnegie & Co, Brandon Capital Partners, and Split Rock Partners
Other Financing Round (2019): $30M featuring M.H. Carnegie & Co., Brandon Capital Partners, Split Rock Partners, Ascension Ventures, and Dr. Thomas Fogarty’s Emergent Medical Partners
Debt (2020): $1M backed by PPP
Key Investors in EBR Systems
Split Rock Partners
Split Rock Partners is a venture capital firm that invests in leading software, Internet services, and healthcare companies across all stages of development. They focus on cloud services, enterprise software and infrastructure, analytics and big data, and marketing technology.
Delphi Ventures
Delphi Ventures is a venture capital firm that has focused on early stage investing in medical devices and biotechnology for two decades, having funded over 150 companies.
Ascension Ventures
Ascension Ventures is a strategic healthcare venture firm launched by one of the nation's largest non-profit health systems, investing in companies that transform the healthcare industry.
What's next for EBR Systems?
With the recent influx of capital, EBR Systems is well-positioned to accelerate its commercialization efforts and expand its clinical footprint. The company's strategic roadmap likely involves deepening its penetration in existing markets while refining its leadless pacing technology to meet the growing demand for minimally invasive cardiac interventions. By leveraging its long-standing relationships with strategic healthcare investors, the firm is poised to transition from a development-focused entity into a broader market leader in cardiac rhythm management, ensuring that its WiSE system becomes a standard of care for patients requiring advanced resynchronization therapy.
See full EBR Systems company page
